www.mdpi.com/2077-0383/14...
www.mdpi.com/2077-0383/14...
CMV, the troll of transplantation😈 is not gonna like this.
@kottonnelson.bsky.social
CMV, the troll of transplantation😈 is not gonna like this.
@kottonnelson.bsky.social
From the Swiss Transport Cohort Study
High rates of IC, predominately intra-abdominal, with decreasing incidence during the study period. Mortality remains high
www.amjtransplant.org/article/S160... #TxID
From the Swiss Transport Cohort Study
High rates of IC, predominately intra-abdominal, with decreasing incidence during the study period. Mortality remains high
www.amjtransplant.org/article/S160... #TxID
link.springer.com/article/10.1...
link.springer.com/article/10.1...
Umut Akova, Rachel Hicklen, Russell E. Lewis, Thomas J. Walsh, Dimitrios P. Kontoyiannis
@cmijournal.bsky.social
www.clinicalmicrobiologyandinfection.com/article/S119...
Umut Akova, Rachel Hicklen, Russell E. Lewis, Thomas J. Walsh, Dimitrios P. Kontoyiannis
@cmijournal.bsky.social
www.clinicalmicrobiologyandinfection.com/article/S119...
This review is based on the authors expert opinions informed by their experiences & literature search
doi.org/10.1080/174740…
This review is based on the authors expert opinions informed by their experiences & literature search
doi.org/10.1080/174740…
oncogenic in SOT recipients (EBV,HHV8, HPV, Merkel cell polyomavirus).
This review discusses the prevention of #EBV & #HHV8 in SOT
👇
pmc.ncbi.nlm.nih.gov/articles/PMC...
#TxID
oncogenic in SOT recipients (EBV,HHV8, HPV, Merkel cell polyomavirus).
This review discusses the prevention of #EBV & #HHV8 in SOT
👇
pmc.ncbi.nlm.nih.gov/articles/PMC...
#TxID
www.dropbox.com/scl/fi/ei4ym...
www.dropbox.com/scl/fi/ei4ym...
While pts may not present to the hospital early after sx onset (median 3.6 days after sx onset), early empiric therapy for influenza is recommended by guidelines supported by a growing literature showing benefit but delays in therapy are common.
While pts may not present to the hospital early after sx onset (median 3.6 days after sx onset), early empiric therapy for influenza is recommended by guidelines supported by a growing literature showing benefit but delays in therapy are common.